VEGFA and COVID-19: In this context, relative gene expression of VEGF-A is upregulated in the lung biopsies of patients who died from COVID-19 compared to the lung biopsies from donator controls [38], and the plasma levels of VEGF-A are higher in SARS-CoV-2-infected patients in the acute phase of the disease than in healthy subjects [33,39], highlighting the relevance of pathologic angiogenesis in active COVID-19 cases.